Jounce Therapeutics, Inc. EPS - Earnings per Share 2017-2022 | JNCE
Jounce Therapeutics, Inc. eps - earnings per share from 2017 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Jounce Therapeutics, Inc. Annual EPS |
| 2022 |
$-0.99 |
| 2021 |
$-1.82 |
| 2020 |
$-1.24 |
| 2019 |
$1.66 |
| 2018 |
$-0.84 |
| 2017 |
$-0.57 |
| 2016 |
$-11.00 |
| 2015 |
$-23.13 |
| 2014 |
$-10.93 |
| Jounce Therapeutics, Inc. Quarterly EPS |
| 2022-12-31 |
$0.98 |
| 2022-09-30 |
$-0.60 |
| 2022-06-30 |
$-0.65 |
| 2022-03-31 |
$-0.72 |
| 2021-12-31 |
$-0.57 |
| 2021-09-30 |
$-0.59 |
| 2021-06-30 |
$-0.08 |
| 2021-03-31 |
$-0.58 |
| 2020-12-31 |
$1.09 |
| 2020-09-30 |
$-0.73 |
| 2020-06-30 |
$-0.82 |
| 2020-03-31 |
$-0.78 |
| 2019-12-31 |
$-0.65 |
| 2019-09-30 |
$2.90 |
| 2019-06-30 |
$-0.21 |
| 2019-03-31 |
$-0.38 |
| 2018-12-31 |
$-0.07 |
| 2018-09-30 |
$-0.23 |
| 2018-06-30 |
$-0.14 |
| 2018-03-31 |
$-0.40 |
| 2017-12-31 |
$-0.31 |
| 2017-09-30 |
$-0.13 |
| 2017-06-30 |
$-0.11 |
| 2017-03-31 |
$-0.02 |
| 2016-12-31 |
$3.01 |
| 2016-09-30 |
$0.03 |
| 2016-06-30 |
$-7.23 |
| 2016-03-31 |
$-6.81 |
